Brief: Armata Pharmaceuticals Announces Q4 And Full-Year 2022 Results And Provides Corporate Update
16/03/2023 22:51
March 16 (Reuters) - Armata Pharmaceuticals Inc
ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND
FULL-YEAR
2022 RESULTS AND PROVIDES CORPORATE UPDATE
* AS OF DECEMBER 31, 2022, ARMATA HELD APPROXIMATELY $14.9
MILLION
OF UNRESTRICTED CASH AND CASH EQUIVALENTS
* QTRLY LOSS PER SHARE $0.29
* Q4 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPnF8yp6a
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles